Elevance Health (ELV) reported its Q2 2026 earnings before the market opened on July 15, 2026. The company reported EPS of 7.45 USD, beating the analyst estimate of 6.21 USD by 19.9%. Revenue reached 49826 million USD. Following the release, the stock price reacted by -8.54%.
Generated automatically from our data — as of July 24, 2026
Key figures at a glance
Estimate (EPS): 6.21 USD
Reported (EPS): 7.45 USD
Price reaction: -8.5%
Frequently asked questions
Did Elevance Health beat or miss earnings-per-share expectations?
Elevance Health beat the analyst estimate of 6.21 USD earnings per share (Q2 2026) by 19.9%, reporting 7.45 USD.
How did Elevance Health stock react to the earnings report?
Elevance Health stock fell 8.5% on the trading day following the release.
What was Elevance Health's revenue in Q2 2026?
Elevance Health reported revenue of 49,826M USD in Q2 2026.